These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 24831884)
21. Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis. Ress K; Teesalu K; Annus T; Putnik U; Lepik K; Luts K; Uibo O; Uibo R BMC Res Notes; 2014 May; 7():310. PubMed ID: 24885370 [TBL] [Abstract][Full Text] [Related]
22. Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis. Sakly W; Mankaï A; Ghdess A; Achour A; Thabet Y; Ghedira I Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):598-603. PubMed ID: 22436429 [TBL] [Abstract][Full Text] [Related]
23. Serological assessment for celiac disease in IgA deficient adults. Wang N; Truedsson L; Elvin K; Andersson BA; Rönnelid J; Mincheva-Nilsson L; Lindkvist A; Ludvigsson JF; Hammarström L; Dahle C PLoS One; 2014; 9(4):e93180. PubMed ID: 24709954 [TBL] [Abstract][Full Text] [Related]
24. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of three serologic tests in childhood celiac disease. Bufler P; Heilig G; Ossiander G; Freudenberg F; Grote V; Koletzko S Z Gastroenterol; 2015 Feb; 53(2):108-14. PubMed ID: 25668712 [TBL] [Abstract][Full Text] [Related]
26. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. Volta U; Granito A; Parisi C; Fabbri A; Fiorini E; Piscaglia M; Tovoli F; Grasso V; Muratori P; Pappas G; De Giorgio R J Clin Gastroenterol; 2010 Mar; 44(3):186-90. PubMed ID: 20042872 [TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - a novel multiplex screen incorporating an integral check for IgA deficiency. Holding S; Wilson F; Spradbery D J Immunol Methods; 2014 Mar; 405():29-34. PubMed ID: 24424297 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population. Bienvenu F; Besson Duvanel C; Seignovert C; Rouzaire P; Lachaux A; Bienvenu J Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1418-23. PubMed ID: 23032795 [TBL] [Abstract][Full Text] [Related]
29. Serological diagnosis of celiac disease: comparative analysis of different strategies. Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X Clin Chim Acta; 2012 Nov; 413(21-22):1761-7. PubMed ID: 22771970 [TBL] [Abstract][Full Text] [Related]
30. Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Maglio M; Tosco A; Auricchio R; Paparo F; Colicchio B; Miele E; Rapacciuolo L; Troncone R Dig Liver Dis; 2011 Aug; 43(8):604-8. PubMed ID: 21342796 [TBL] [Abstract][Full Text] [Related]
32. Celiac disease prevalence in patients with idiopathic inflammatory myopathies, a cross-sectional study. González-Leal RÁ; Torres-Ruiz J; Mejía-Domínguez NR; Núñez-Álvarez CA; Pérez-González B; Uscanga-Domínguez LF; Gómez-Martín D Clin Rheumatol; 2024 Jul; 43(7):2253-2260. PubMed ID: 38842744 [TBL] [Abstract][Full Text] [Related]
33. Prospective antibody case finding of coeliac disease in type-1 diabetes children: need of biopsy revisited. Popp A; Mihu M; Munteanu M; Ene A; Dutescu M; Colcer F; Raducanu D; Laurila K; Anca I; Mäki M Acta Paediatr; 2013 Mar; 102(3):e102-6. PubMed ID: 23211000 [TBL] [Abstract][Full Text] [Related]
34. A 10-year serological follow-up of celiac disease in an Estonian population. Lillemäe K; Ress K; Harro J; Merenäkk L; Maaroos HI; Uibo R; Uibo O Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):55-8. PubMed ID: 22008627 [TBL] [Abstract][Full Text] [Related]
35. Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome. Shamaly H; Hartman C; Pollack S; Hujerat M; Katz R; Gideoni O; Shamir R J Pediatr Gastroenterol Nutr; 2007 May; 44(5):583-6. PubMed ID: 17460490 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease. Abu-Zekry M; Kryszak D; Diab M; Catassi C; Fasano A J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):136-40. PubMed ID: 18664863 [TBL] [Abstract][Full Text] [Related]
38. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593 [TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524 [TBL] [Abstract][Full Text] [Related]
40. Overview of biomarkers for diagnosis and monitoring of celiac disease. Brusca I Adv Clin Chem; 2015; 68():1-55. PubMed ID: 25858867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]